Category Press Releases

View current press releases, to submit a press release please contact [email protected] for pricing.

Umicore revises slightly its 2023 outlook

Umicore revises slightly its 2023 outlook Umicore revises slightly its full year 2023 outlook and now expects adjusted EBIT to approach € 1 billion. This compares to the previous expectation of adjusted EBIT slightly exceeding € 1 billion as communicated…

Innovent Announces ORIENT-31, a Phase 3 Study of Sintilimab in Patients with EGFR-Mutated Nonsquamous Non-Small Cell Lung Cancer with Prior EGFR-TKI Treatment, Has Met Primary Endpoint

SAN FRANCISCO and SUZHOU, China, Oct. 17, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today announced…